A 55 year-old man with unstable angina is treated with an intravenously administered glycoprotein IIb - IIIa inhibitor. The mechanism of action of this agent is the ability to.
Solution:
Glycoprotein IIb - IIIa

Prevent the action of the platelet surface receptor glycoprotein complex, which is mrequired for formation of fibrinogen bridges between adjacent platelets.
Thus inhibiting platelet aggregation.
Dilate coronary arteries
Inhibit platelet aggregation
Inhibit platelet adhesion
Inhibit atherogenesis